11-8-17 9:41 AM EST | Email Article

LAVAL, Quebec (AP) _ Bellus Health Inc. (BLUSF) on Wednesday reported a loss of $1.3 million in its third quarter.

On a per-share basis, the Laval, Quebec-based company said it had a loss of 2 cents.

The drug developer posted revenue of $74,200 in the period. Its adjusted revenue was $74,000.

The company's shares closed at 32 cents. A year ago, they were trading at 20 cents.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUSF at https://www.zacks.com/ap/BLUSF

Add a Comment

Try Premium Membership today. Your first 14 days are free of charge. Start my Premium Membership Trial.
Sponsored Links
Buy a Link Now
Sponsor Center
Content Partners